Currency

USD: $ ^

Recombinant human LIF protein (Qk036)

Human LIF (leukemia inhibitory factor) suppresses the differentiation of murine embryonic stem cells (ESCs) and is widely used in ESC and induced pluripotent stem cell (iPSC) culture.

Qkine human LIF protein is a 17 kDa highly pure, bioactive, animal origin-free and carrier-protein free for reproducible results in stem cell culture.

Orders are typically shipped same or next day (except Friday).
Easy world-wide ordering, direct or through our distributors.

1000µg will be despatched as 2 x 500µg

Fast and free shipping.
Buy online with secure credit card or purchase order.
For any questions, please email orders@qkine.com

Summary

  • High purity human LIF protein (Uniprot: P15018)

  • >98%, by SDS-PAGE quantitative densitometry

  • 17 kDa

  • Expressed in E. coli.

  • Animal origin-free (AOF) and carrier protein-free.

  • Manufactured in our Cambridge, UK laboratories

  • Lyophilized from acetonitrile, TFA

  • Resuspend in 10mM HCl at >100 µg/ml (provided with protein and free of charge), prepare single use aliquots, add carrier protein if desired and store frozen at -20°C or -80°C

Featured applications

  • Propagation of ES cells in feeder or feeder-free chemically defined culture systems

  • Human LIF can be used in the maintenance of murine ESCs

Leukemia inhibitory factor, Differentiation-stimulating factor, D factor, melanoma-derived LPL inhibitor (MLPLI)

Human

Species similarity:

Bovine – 88%


Porcine – 87%


Rat – 83%


Mouse – 78%

Bioactivity

Human LIF Qk036 protein bioactivity lot #14293

Human LIF activity is determined using the LIF-responsive firefly luciferase reporter assay. HEK293T cells are treated in triplicate with a serial dilution of LIF overnight. Firefly luciferase activity is measured and normalised to the control Renilla luciferase activity. EC50 = 16.8 pM (0.29 ng/mL). Data from Qk036 lot #104293.

Purity

Human LIF Qk036 protein purity SDS-PAGE lot #14293

Human LIF protein (Qk036) migrates as a single band at 20 kDa in non-reducing (NR) and upon reduction (R). Purified recombinant human LIF protein (3 μg) was resolved using 15% w/v SDS-PAGE in reduced (+β-mercaptoethanol, R) and non-reduced conditions (NR) and stained with Coomassie Brilliant Blue R250. Data from Qk036 lot #104293.

Further quality assays

  • Mass spectrometry: single species with expected mass

  • Analytical reversed-phase: single sharp peak

  • Endotoxin: <0.005 EU/μg protein (below level of detection)

  • Recovery from stock vial >95%

We are a company founded and run by scientists to support innovation in stem cell biology and regenerative medicine. To enhance reliability and reproducibility in your applications, all our products are exceptionally high purity, with complete characterisation and bioactivity analysis on every lot.

Qkine human LIF is as biologically active as the comparable alternative supplier protein

Quantitative luciferase assay with Qkine LIF (Qk036, green) and alternative supplier LIF (Supplier B, black). Cells were treated in triplicate with a serial dilution of LIF for 24 hours. Firefly luciferase activity was measured and normalized to control Renilla luciferase activity.

Protein background

LIF is a pleiotropic factor that belongs to the IL-6 superfamily of cytokines. LIF is expressed as a 202 amino acid precursor which is processed by the removal of 22 animo acids from the N-terminus, which is important for receptor binding [1]. LIF acts through the heterodimeric receptor of LIFR (gp190)/gp130 [1, 2]. Although this receptor is shared by other cytokines, LIF stands out as it can have opposite effects depending on cell type, either stimulating or inhibiting cell proliferation and differentiation. LIF activates several cellular signaling pathways including the JAK/STAT, PI3K and MAPK pathways [1].

LIF signaling is essential for maintenance of murine ESC pluripotency through STAT3 signaling [2]. In neural stem cell (NSC) culture LIF can have complex and potentially contradictory effects. LIF enhances NCS self-renewal but can also promote gliogenesis, depending on the context and presence of other growth factors, such as epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2) [3].

[1] N. A. Nicola and J. J. Babon. Leukemia Inhibitory Factor (LIF). Cytokine Growth Factor Rev 26, 533–544 (2015). doi: 10.1016/j.cytogfr.2015.07.001

[2] Graf, U., Casanova, E. A. & Cinelli, P. The Role of the Leukemia Inhibitory Factor (LIF) — Pathway in Derivation and Maintenance of Murine Pluripotent Stem Cells. Genes (Basel) 2, 280–297 (2011). doi: 10.3390/genes2010280

[3] M. Pitman, B. Emery, M. Binder, S. Wang, H. Butzkueven, T.J. Kilpatrick. LIF receptor signaling modulates neural stem cell renewal. Molecular and Cellular Neuroscience 27:3, 255-266 (2004). doi.org/10.1016/j.mcn.2004.07.004

Publications

KLF7 is a general inducer of human pluripotency
Preprint on 6 September 2023 by Arboit, M. et al.

Esrrb guides naive pluripotent cells through the formative transcriptional programme
In Nature Cell Biology on 27 April 2023 by Carbognin, E. et al.

STAT3 and HIF1α cooperatively mediate the transcriptional and physiological responses to hypoxia
In Cell Death Discovery on 5 July 2023 by Dinarello, A. et al.

Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity
In Nature Communications on 5 July 2023 by Ferlazzo, G. M. et al.

Self-renewing human naïve pluripotent stem cells dedifferentiate in 3D culture and form blastoids spontaneously
In Nature Communications on 22 January 2024 by Guo, M., Wu, J., Chen, C. et al.

Generating human blastoids modelling blastocyst-stage embryos and implantation
In Nature Protocols on 15 February 2023 by Heidari Khoei, H., Javali, A., Kagawa, H. et al.

ERK signalling eliminates Nanog and maintains Oct4 to drive the formative pluripotency transition
In Development on 26 July 2024 by Mulas, C. et al.

Metabolic rewiring underpins human trophoblast induction
Preprint on 18 Mar, 2024 by Żylicz, J. et al.

FAQ

Leukemia inhibitory factor (LIF) is an interleukin 6 class cytokine, named for its ability to induce the terminal differentiation of myeloid leukemia cells.

In the early developing embryo, LIF is expressed in the trophectoderm.

LIF binds to the heterodimeric receptor LIFR (gp190)/gp130.

LIF activates several cellular signaling pathways including the JAK/STAT, PI3K and MAPK pathways.

LIF can be added to feeder-free stem cell cultures, it promotes self-renewal by recruiting signal transducer and activator of transcription 3 (Stat3).

Our products are for research use only and not for diagnostic or therapeutic use.  Products are not for resale.

Share your thoughts!

Let us know what you think...

What others are saying

There are no contributions yet.

×

Login

Register


Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.

Continue as a Guest

Don't have an account? Sign Up

Amazon gift voucher available for growth factor and cytokine reviews

Receive an Amazon gift voucher when you leave us a review.

£25, $30 or €30 for reviews with an image and £10, $15 or €15 for reviews without an image
Terms and conditions apply